242 related articles for article (PubMed ID: 22114493)
1. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
3. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
4. Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying.
Wan F; Bohr A; Maltesen MJ; Bjerregaard S; Foged C; Rantanen J; Yang M
Pharm Res; 2013 Apr; 30(4):1065-76. PubMed ID: 23263784
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
[TBL] [Abstract][Full Text] [Related]
7. Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
Dhanda DS; Tyagi P; Mirvish SS; Kompella UB
J Control Release; 2013 Jun; 168(3):239-50. PubMed ID: 23562638
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release.
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
J Pharm Sci; 2013 Mar; 102(3):1036-53. PubMed ID: 23293035
[TBL] [Abstract][Full Text] [Related]
10. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
12. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
13. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
16. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.
Jeon HJ; Jeong YI; Jang MK; Park YH; Nah JW
Int J Pharm; 2000 Oct; 207(1-2):99-108. PubMed ID: 11036235
[TBL] [Abstract][Full Text] [Related]
17. Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.
Bohr A; Kristensen J; Dyas M; Edirisinghe M; Stride E
J R Soc Interface; 2012 Oct; 9(75):2437-49. PubMed ID: 22535697
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles.
Cooper DL; Harirforoosh S
PLoS One; 2014; 9(12):e113558. PubMed ID: 25502102
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
Zhang YH; Zhang H; Liu JM; Yue ZJ
Med Oncol; 2011 Sep; 28(3):901-6. PubMed ID: 20396980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]